Colgate-Palmolive Reports Solid Q2 Growth Despite U.S. Market Pressures
The consumer goods giant delivered broad-based organic sales growth and margin expansion, though domestic performance lagged international momentum.
Strong International Performance Offsets Domestic Weakness
Colgate-Palmolive Company delivered another quarter of "strong top and bottom line growth" in Q2 2026, with organic sales growth across four of five divisions and three of four categories, CEO Noel Wallace said on the company's July 31 earnings call. The $73 billion consumer goods company reported gross margin expansion of 100 basis points, with 90 basis points coming from core business operations excluding modest tariff benefits.
The quarter's growth was "led by emerging markets, which were up mid-single digits, driven by India, Brazil, Mexico and China," Wallace noted. European markets also contributed "strong" performance through innovation and market share gains. Free cash flow increased 18%, and the company returned $1.4 billion to shareholders during the period (earnings call, 2026-07-31).
However, Wallace acknowledged the company "was not satisfied" with U.S. performance, prompting strategic interventions for the second half.
Hill's Pet Nutrition Outperforms Flat Category
The Hill's pet nutrition division demonstrated resilience amid soft category dynamics, delivering 4% organic growth excluding private label discontinuations in a "more or less flat" U.S. market. The business grew across all focused segments except Science Diet dog food, which faced headwinds from consumer migration to smaller pets.
Particularly impressive was the therapeutic business, which Wallace said "continues to grow very, very nicely, both from volume and pricing," driving positive mix and margin acceleration. The division increased advertising as a percentage of sales and performed well on Amazon Prime Day.
The company's fresh pet food initiative, building on lessons from the Prime brand launch in Australia, is rolling out in the U.S. with "3 single protein diets" focused on professional veterinary channels. Wallace emphasized a deliberate approach: "We're not leaning to generate significant volume right now. We're looking to really build the brand and underscore the science."
U.S. Turnaround Strategy Takes Shape
To address domestic market underperformance, Colgate outlined three key initiatives: scaling 2026-2027 innovation including Optic White Pro Series with Active Shine technology and Fabuloso new forms; taking "surgical actions by category and channel to drive market share improvement"; and increasing brand support across core businesses.
The company reported "double-digit increase in advertising" for the quarter while maintaining profitability despite "significant cost inflation." Wallace credited revenue growth management tools, including scaled promotional AI capabilities, and "strong funding growth in the quarter" for enabling simultaneous investment in brands and earnings growth.
Gross margin strength came primarily from core business execution rather than one-time benefits. "We got a little bit a modest benefit from refunds, but the bulk of the growth definitely came through our core business," Wallace explained, adding that future tariff refunds would be "very insignificant."
The quarter marked a bittersweet milestone as the company announced CFO John Faucher's retirement after 40 quarterly earnings calls with Colgate. Wallace praised Faucher's "rare combination of investor perspective, great business judgment and strategic thinking."
Looking ahead, Wallace expressed optimism: "We've executed a strong first half of the year. While there are still some uncertainties ahead, we are optimistic the strength of our global model will continue to do both in the short term and set us up for long-term success" (earnings call, 2026-07-31).
This article was generated by MarginX from the earnings call on 2026-07-31. It is not investment advice.